The carbohydrate response element binding protein (CHREBP) is downregulated in gastric cancer and inhibits Cyclin D1 levels in gastric cancer cells in order to suppress growth via negative modulation of the Cyclin D1-Rb-E2F1 signaling mechanism [82]. The gene discussed is E2F1; the disease is gastric cancer.